Publication
Glypican-3-Targeted Paired Radiotheranostics in Orthotopic Liver Cancer Models.
Woonghee Lee, Joon-Yong Chung, Stephen Adler, Falguni Basuli, Kwamena Baidoo, Jianfeng Shi, Yuki Ueda, Satoshi Omiya, Divya Nambiar, Hima Makala, Julia Sheehan-Klenk, Stanley Fayn, Colleen P Olkowski, A Paden King, Benjamin Ruf, Tim F Greten, Orit Jacobson, Peter L Choyke, Freddy E Escorcia
- Source
- PubMed
- Retrieved
- Sep 18, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260918-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
PURPOSE: Glypican-3 (GPC3), highly expressed in the most common liver cancer hepatocellular carcinoma (HCC) but absent from normal liver, represents an attractive tumor-selective target. We evaluated GPC3-targeted paired PET diagnostic and alpha particle therapeutic (radiotheranostic) agents in…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Liver Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available